Denali Therapeutics Inc. (FRA:4DN)
17.75
+1.74 (10.87%)
At close: Jan 23, 2026
-20.76% (1Y)
| Market Cap | 2.86B -5.0% |
| Revenue (ttm) | n/a |
| Net Income | -425.08M |
| EPS | -2.48 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 77 |
| Open | 17.75 |
| Previous Close | 16.01 |
| Day's Range | 17.75 - 17.75 |
| 52-Week Range | 10.17 - 22.95 |
| Beta | n/a |
| RSI | 63.80 |
| Earnings Date | Feb 27, 2026 |